Michel Obéid

13.9k citations
41 papers · 7.4k · 4 hit papers · h-index 22

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Phagocytosis and Immune Regulation
    • Immune cells in cancer
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Cancer Immunotherapy and Biomarkers 25
    • CAR-T cell therapy research 6
    • Colorectal Cancer Treatments and Studies 5
    • Phagocytosis and Immune Regulation 8
    • Immune Cell Function and Interaction 6
    • Immunotherapy and Immune Responses 4

Michel Obéid

40 papers receiving 7.3k citations

Michel Obéid's Hit Papers

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 2022 · 565 citations
5650+7+14Years since publication50010001.5k2.0k2.5k

Peers

Michel Obéid
Comparison fields: 5 of 125
  • Immunology 3.5k
  • Oncology 4.2k
  • Physiology 181
  • Pulmonary and Respiratory Medicine 1.1k
  • Biotechnology 260
Replace Radek Špíšek with:
Radek Špíšek Czechia
Aitziber Buqué United States
Nathalie Chaput France
Encouse B. Golden United States
Veena Kapoor United States
Antoine Tesnière France
Andréas Mackensen Germany
Walter J. Urba United States
Jeffrey A. Drebin United States
Koji Kono Japan
Michel Obéid relative to Radek Špíšek Czechia Radek Špíšek's profile →
Citations per field
00.5×1.5×2.3×
Radek Špíšek · 1×
Citations per year

Countries citing papers authored by Michel Obéid

Since Specialization
Citations

This map shows the geographic impact of Michel Obéid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Obéid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Obéid more than expected).

Fields of papers citing papers by Michel Obéid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Obéid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Obéid. The network helps show where Michel Obéid may publish in the future.

Co-authors

The 25 scholars most cited alongside Michel Obéid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michel Obéid Line = papers co-authored together Michel Obéid links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Calreticulin exposure dictates the immunogenicity of cancer cell death
Hit paper breakdown →
20062518
2
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Hit paper breakdown →
20191544
3
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Hit paper breakdown →
20051212
4
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Hit paper breakdown →
2022565
5 2007180
6 2020153
7 2019141
8 2007135
9 2020124
10 200884
11 202376
12 202174
13 200769
14 201859
15 202153
16 202149
17 202242
18 202041
19 202036
20 201230

About Michel Obéid

Michel Obéid is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 41 papers that have together received 7.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Phagocytosis and Immune Regulation (8 papers), Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Immunotherapy and Immune Responses (4 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Immunology (3.5k citations), Oncology (4.2k citations), Physiology (181 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Biotechnology (260 citations). Michel Obéid has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Laurence Zitvogel, François Ghiringhelli, Guido Kroemer, Antoine Tesnière, Didier Métivier, Noëlia Casares, Solange Peters, Lionel Apétoh, Theocharis Panaretakis and Peter Van Endert. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Annals of Oncology, Journal of Clinical Oncology, Nature Reviews Clinical Oncology and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact